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Abstract 
 
The Analytical Country Reports analyse and assess in a structured manner the evolution of the national policy research 
and innovation in the perspective of the wider EU strategy and goals, with a particular focus on the performance of the 
national research and innovation (R&I) system, their broader policy mix and governance. The 2013 edition of the Country 
Reports highlight national policy and system developments occurring since late 2012 and assess, through dedicated 
sections:  
 national progress in addressing Research and Innovation system challenges; 
 national progress in addressing the 5 ERA priorities; 
 the progress at Member State level towards achieving the Innovation Union; 
 the status and relevant features of Regional and/or National Research and Innovation Strategies on Smart 
Specialisation (RIS3); 
 as far relevant, country Specific Research and Innovation (R&I) Recommendations. 
Detailed annexes in tabular form provide access to country information in a concise and synthetic manner. 
The reports were originally produced in December 2013, focusing on policy developments occurring over the preceding 
twelve months. 
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EXECUTIVE SUMMARY 
 
 
The political context in Israel in 2013, has been marked by the early elections for the 19th 
Knesset (Israeli parliament), held in Israel on 22nd of January 2013. The results of the elections 
showed that Israeli population voted for change in government. For the first time since 1999, 
Shah, the ultra-orthodox religious party, is not part of the coalition. 
 
During the summer of 2013 negotiations started in relation to Israel’s participation in Horizon 
2020. The main issue was the guideline for the eligibility of Israeli entities and their activities in 
areas outside the 1967 line.1 The decisions concerned grants, prizes and financial instruments 
funded by EU from 2014 onwards. After months of intense negotiations, the EU High 
Commissioner Catherine Ashton and Israeli Justice Minister Tzipi Livni reached an agreement. 
This agreement fully respects the EU's financial requirements while at the same time respecting 
Israel's political sensitivities and preserving its principled positions. 
 
Israel has been less affected by the crisis, and during 2012 continued growing at a 3.4%.  
However during 2012, the economy’s growth rate has slowed in comparison with 4.6% reached 
in 2011. This slow down derives from the global crisis, which impacted Israeli exports, raised 
fuel prices and a moderation in the expansion of the construction industry. The unemployment 
rate remained stable at low levels (6.85%). 
 
Israel is a highly innovative country, and is situated well above the EU average for the majority 
of the R&I indicators. Indeed, its level of innovation performance places it among the group of 
European “innovation leaders”. Only Sweden, Switzerland and Finland show higher levels of 
innovation performance. Israel is ranked second (to the United States) worldwide in terms of 
venture capital availability, thus ensuring the right conditions for highly innovative small 
companies across all sectors. (European Commission 2013). 
 
Despite its high level of R&D investments, the global economic crisis has had a mild impact on 
R&D funding in Israel. GERD, measured as a percentage of GDP, has been in constant decline, 
falling from 4.17% in 2009 to 3.93% in 2012, notwithstanding a marked increase in government 
expenditure (GBOARD). This highlights the very high exposure of the research and innovation 
system to global financial conditions, which stems from the very high share of business in 
funding R&D.  The contribution of the business sector to the funding of R&D, keeps on rising, 
with its share of GERD reaching 84.5% in 2012. 
 
There were no major changes in the governance of the government-funded RDI system, but 
there were strong indications of increased involvement of the Finance Ministry as a coordinator 
and driver of links between research and innovation policy. The two main RDI bodies -- the 
Council of Higher Education (CHE), through its Planning and Budgetary Committee (Vatat), 
and the Office of the Chief Scientist (OCS) in the Ministry of Industry, Trade and Employment 
– charged with making and executing research and innovation policy respectively have different 
missions and traditionally cooperated only on an ad hoc basis. However, an increasing number 
of programmes are being launched in tandem by both agencies or by the OCS and the Finance 
Ministry. 
                                                 
1 The 1967 line refers to the demarcation lines set out in the 1949 Armistice Agreements between Israel and its 
neighbours (Egypt, Jordan, Lebanon and Syria) after the 1948 Arab–Israeli War. The 1967 Line is also used to mark 
the line between Israel and the territories captured in the Six-Day War, including the West Bank, Gaza Strip, Golan 
Heights and Sinai Peninsula 
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The Israeli RDI system faces the following three major structural challenges that require 
systematic solutions: 
Reviving research in Israeli universities: Budgets for Israeli universities essentially stagnated 
during the first decade of the century despite a growth in student numbers, leading to a decline 
in bibliometric scores.  
Over-reliance on ICT: Companies dealing with computing and communications technologies are 
one of the mainstays of the Israeli economy. However, the period of explosive growth for ICT is 
over globally and policymakers have been trying for a number of years through several 
instruments to find new engines of growth. 
Precarious state of Venture Capital: Returns on VC investments in Israel by and large match 
returns in the US, where results have been disappointing compared to other financial 
investments during the past decade. 
Israeli RDI governance does not have a tradition of formally articulating priorities as part of an 
open policy making process. Nevertheless, the new Vatat six-year plan does lay out a clear vision, 
and by implication, of a set of priorities chiefly calling both for a higher degree of excellence and 
a higher degree of specialisation in university research. 
 
The priorities of the OCS are reflected in the changing nature of measures issued over the years. 
A major shift during the past few years has been the inclusion of priorities with a 
societal/economic slant beyond the traditional OCS approach of encouraging technological 
excellence wherever it happens. These priorities range from measures to improve innovation in 
traditional industries to measures to encourage technology firms to set up operations in 
peripheral parts of the country. 
 
In terms of venture capital in 2011, the Finance Ministry’s decision to insure a quarter of the risk 
of Israeli institutional investors, who join funds as limited partners, is a direct reaction to this 
priority. During 2013 high-tech companies attracted €1,78 bn. the highest amount in the past 10 
years. This fact can be interpreted as a positive reaction toward the government policy from the 
Israeli VC industry. However, the effectiveness of the response depends on so many extraneous 
factors that it is hard to judge on its own merits 
 
Looking at the match between the challenges, priorities and means used to address the needs of 
the RDI system, Vatat's six year plan, coupled with the I-CORE project, seems to be a 
comprehensive approach that looks towards creating foci of research excellence while reviving 
the entire academic research sector.  
 
The need to diversify beyond ICT is a far more complex challenge because it involves creating 
an infrastructure not only of research but also of human skills and the financial means to realize 
commercial potential. The creation of the government backed biotech VC fund is a step in the 
right direction as are a number of OCS measures intended to stimulate non-ICT innovation 
issued during the past few years. But the challenge is deeper because of the breadth of the 
scientific and technological infrastructure needed to create new areas of high added value for 
Israel's knowledge intensive industries. 
 
In terms of ERA objectives the areas that received the most emphasis during 2013 were largely 
unchanged: the major tasks of research institutions and the closely related fields of research 
infrastructures and the labour market for researchers 
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1. BASIC CHARACTERISATION OF THE 
RESEARCH AND INNOVATION SYSTEM 
Israel is a small country with a population of population of 8.05 million as of August 2013. In 
2012, GDP per capita reached € 24,9002 and GDP growth 3.4%. Also during 2012 the 
economy’s growth rate moderated as compared to 4.6 % in 2011. This slowdown in growth 
began in the middle of 2011 and a further slowdown was recorded at the end of 2012. This 
moderation in growth derives primarily from the global slowdown in growth, which negatively 
impacted Israeli exports, and was also the result of an increase in the cost of fuel imports. Also, 
the moderation in the rate of expansion of the construction industry explains about one-fifth of 
the slowdown in growth this year (Bank of Israel 2012a)  
 
Research and innovation are central pillars of the economy. GERD reached 4.0% of GDP in 
2012 compared to the EU average of 2.06% in 2012, with the business sector playing a major 
part in funding R&D. BERD accounted for 84.5% of GERD compared to the EU average of 
63% in 2012 and for 3.93% of GDP compared to the EU average of 2.06%. The government's 
role in funding university-based research is commensurately smaller, with R&D performed by 
HEIs reaching 12.6%, compared to the EU average of 24% 
 
Research input in terms of human skills is satisfactory in relation to other OECD countries. The 
average number of years of schooling among the population in the principal working age range 
(25–64), which is an indicator of the stock of human capital in the economy, grew in Israel from 
10.1 years in 1974 to 13.4 years in 2011. In 2012, Israel ranked 16th among advanced economies 
(OECD). During 2012, 11,200 new doctorates were granted for students in the age range 25-35, 
which makes a proportion of 1,4 new doctorates for every 1000 people. However, the OECD 
and the Bank of Israel forecast a less promising situation for the future due to the lower levels of 
educational attainment among Arabs and ultra-orthodox Jews that make up to 20% of the 
population(Bank of Israel 2013).   
 
Israel is well above the EU average for the majority of the R&I indicators (European 
Commission 2013). Indeed, Israel’s overall level of innovation performance places it among the 
group of European “innovation leaders”. PCT patent applications per billion GDP are three 
times higher than the EU average, a remarkable difference (despite an average annual decrease of 
1.43% over the period 2000-2010).  
 
Although the supply of human resources for science and technology is below the EU average for 
new science and technology graduates and new doctoral graduates per thousand population aged 
25-34, knowledge production as evidenced by highly-cited scientific publications is at the same 
level as the EU average indicating a good scientific base. This is confirmed by Israel's remarkable 
level of participation as an associated country in the 7th Framework Programme: Israel has four 
institutions3 in the top 50 participant HES organisations in signed grant agreements for the 
period 2007-2010. 
 
                                                 
2 (OECD 2013) 
3 Hebrew University of Jerusalem, Weizmann Institute of Science, Technion and Tel-Aviv University. 
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Research infrastructures have been largely neglected between 2000 and 2010. An exception is the 
area of nanotechnology, which was addressed by the Israel Nanotechnology Initiative, funded 
partly by the government and partly by donors. The Vatat six-year plan is supposed to address 
this issue, partly through the I-CORE centres (Israeli Centres of Research Excellence), which can 
be seen as roughly equivalent to the European RI roadmap. 
 
Chart 1. The Israeli R&D Innovation System 
The main players in Israel's national research and innovation system, responsible for policy-
making and governance, remain the Office of the Chief Scientist (OCS) in the Ministry of   
Economy responsible for industrial R&D, and the Planning & Budgeting Committee (known as 
the Vatat) of the Council for Higher Education, which covers academic R&D. However, since 
2011, the Ministry of Finance, the ultimate source of funds for R&D initiated by the government 
and academy (GBAORD and HERD respectively), has become much more involved in 
innovation policy making. The heightened involvement of the Finance Ministry has helped 
increase the cooperation and coordination between all entities involved in innovation policy, 
including the OCS and Vatat.  
 
Operating with a smaller budget, the Ministry of Science, Technology and Space funds some 
small thematic research centres, runs 10 small regional research centres and is responsible for 
some aspects of international scientific cooperation. Under this Ministry's aegis is the National 
Council for Research and Development, a body that has statutory authority to devise policy and 
advise the government, but has proved largely ineffective in recent years. 
 
Outside of government, most academic research is carried out in seven research universities. 
PROs do not play a central role except in the field of agriculture. R&D in the business sector is 
divided between indigenous firms, many of which went public on NASDAQ, subsidiaries of 
multinational, mainly American corporations, and a large number of technological start-up 
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companies. Many of the local subsidiaries of multinationals were set up after the acquisition of 
local start-ups. One of the problems of Israel's relatively large venture capital industry, (see 
section 3), is that is has become far more difficult to float Israeli companies on NASDAQ, the 
preferred option in terms of liquidity and visibility, meaning that most of the prevalent strategy 
for Israeli start-ups is through M&A.  
 
In terms of specialisation, there are two main fields of expertise, one which has been translated 
into noted commercial success and another which has only partially delivered on expectations. 
There is a broad range of distinct successful ICT clusters in Israel with expertise ranging from 
semiconductors though communications to data security and various kinds of software. 
Academically, life sciences are another strong suit but this has been translated into notable 
success only in the field of medical devices. Persistent government efforts to stimulate 
commercial success in pharmaceutical biotechnology have won only partial success (excluding 
Teva Pharmaceutical Industries – a very large international firm based in Israel). Another major 
area of expertise in knowledge intensive industries is defence exports, about which most 
information is classified. Press reports estimated the total volume of defence exports in 2012 at 
more than €5.8 bn4. About 80% of the output of Israel's defence industries goes to exports, since 
the Israeli army cannot on its own finance the immense costs involved in developing modern 
weapons systems.   
                                                 
4 (Jerusalem Post 2013) 
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2. RECENT DEVELOPMENTS OF THE 
RESEARCH AND INNOVATION POLICY 
AND SYSTEM  
2.1 National economic and political context 
 
The political context in Israel in 2013 has been marked by the early elections for the 19th 
Knesset (Israeli parliament), held in Israel on 22nd of January 2013. Public debate over the “Tal 
law”, which allows an exemption for Ultra-Orthodox students to military service, had nearly led 
to early elections in 2012, but they were aborted at the last moment after Kadima briefly joined 
the government. The elections were later called in October 2012 after a failure to agree on the 
budget for 2013 fiscal year. 
 
In the elections, the Israeli population voted for change in government. Likud, Benjamin 
Netanyahu’s party, losing eleven seats, emerged as the largest faction in the Knesset. However it 
was considered, together with Kadima as the big loser of the election. Yesh Atid, a new centre 
left party emerged as the second largest party in Israel. Considered as a big electoral success, 
Yesh Atid received nineteen Knesset seats. Likud Leader, Benjamin Netanyahu, formed the 
thirty third government, after establishing a coalition with Yesh Atid, the Jewish Home and 
Hatnuah, which between them held sixty-eight seats. For the first time since 1999, Shah, the 
ultra-orthodox religious party, is not part of the coalition. 
 
The growth of the Israeli economy decelerated during 2012 to 3.4%5, against the background of 
the global slowdown. Increased expenditure on energy imports and a slowdown in the expansion 
of the construction industry also contributed to the slowdown in growth. In response, monetary 
and fiscal policy both supported the expansion of activity. Inflation in 2012 of 1.6 % fluctuated 
within the lower part of the target range (1-3%)6. 
 
According to the Bank of Israel, in 2012, the rate of economic growth slowed relative to the 
previous year, primarily as a result of the slowdown in demand worldwide. An analysis of growth 
figures indicates that the slowdown began in mid-2011 and that during most of 2012 the rate of 
growth remained relatively stable, with additional slowing in the final quarter. Another 
contribution to the slowdown in economic growth derived from the slowdown in growth of the 
construction industry. The participation rate increased, as did the rate of employment. However, 
there was no change in labour productivity. The unemployment rate remained stable. The 
production potential of the economy expanded this year, but as labour productivity remained 
unchanged, it appears that the potential for growth has not been fully realised. The real exchange 
rate depreciated relative to the previous year in terms of the annual average and the surplus in 
the current account disappeared, a reflection of the slowdown in exports and the increased 
expenditure on energy.  
 
Growth in three of the main components of GDP — exports, private consumption and  
investment — slowed during 2012 in comparison to 2010 and the first half of 2011. Exports 
were affected directly by the slowdown in world trade. In 2012, world trade grew by 2.8 
                                                 
5 Last Available data from Central Bureau of Statistics Israel, December 2013. 
6 (Bank of Israel 2012) 
http://www.boi.org.il/en/NewsAndPublications/RegularPublications/Research%20Department%20Publications/
BankIsraelAnnualReport/Annual%20Report%20-%202012/p3.pdf 
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percent, which was low relative to both 2010 and 2011 and relative to the average growth rate in 
each of the two decades preceding the crisis of 2008. As a result, Israeli exports grew only 
moderately and if it had not been for the contribution to exports of the new Intel factory, 
exports would virtually have not grown at all. 
 
Private consumption and investment were also affected by the global slowdown, although in this 
case it is more difficult to identify the channels through which this occurred. Private 
consumption was influenced through the effect of exports on disposable income and also 
through a separate channel involving the expectations of future income. With regard to the latter, 
the worsening of the debt crisis in Europe during the year increased pessimism with respect to 
the timing of Europe’s recovery, which in turn reinforced the drop in domestic private 
consumption and the increase in private saving. The slowdown in expansion of private 
consumption was manifested primarily in the consumption of durable goods, which are more 
sensitive to fluctuations in income.  
 
The slowdown in expansion of investment in the economy was the result of expectations of 
continued slowdown in growth of GDP and risk associated to geopolitical situation of Israel. 
The uncertainty of investment in Israel has grown due to the concern of a military confrontation 
with Iran, changes of regimes in neighbouring countries, and the civil war in Syria.  
 
Despite the slowdown in the rate of growth, the labour force participation rate continued to 
grow during 2012, and the unemployment rate, with an annual average of 6.85%, remained stable 
at low levels. The lack of change in the unemployment rate was primarily the result of the 
flexibility in wages and work hours in the economy. This flexibility is evident from the previous 
two crises, i.e., 2001–02 and 2008–09, during which workers shared the burden of reduced 
profits with employers through working fewer hours and a reduction in the level of wages. This 
makes it easier for employers to hire new workers according to the needs of the business even 
when there is concern of a slowdown, and allows them to minimize the number of workers laid 
off. The number of employees in the economy increased this year by 3.4 percent which is similar 
to the rate of growth in GDP. This implies that worker productivity did not grow this year, 
compared with its average annual increase of about one percent during the period 1996 to 2010. 
This is also an indication that the rate of growth in GDP this year was below its potential. 
 
Additional matters concerning the political situation of Israel are: 
 
- The discovery of a natural gas reserve in Tamar is expected to reach consumers in towards the 
end of 2013. This will have several implications for the economy, primarily a reduction in the 
cost of electricity production, a reduction in the cost of energy for industry, and it will increase 
certainty over energy price levels. 
 
- Social protests against government policy. Although the demonstrations of summer 2011 have 
ended, their effects remain present in government policy.  Following the protests, the President 
formed a Committee to investigate the situation headed by the economist Professor Manuel 
Trajtenberg. The government and the Knesset accepted nearly all of the Trajtenberg 
Committee’s recommendations in the area of taxation. They represented a change in policy that 
before had been always aimed at reducing the size of government. They recommended tax 
increases over expenditures cuts, expand free education, aid for working parents with young 
children and recommend cutting defence budget. However, while the government refrained 
from making such a cut, the overall conclusion of the recommendations was to increase 
spending in social services. 
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2.2 Funding trends  
2. 2.1. Funding flows 
  
Table 1. Basic indicators for R&D investments7. 
 
  2009 2010 2011 2012 
EU 
Average 
2012 
GDP growth rate 1.2 (%) 5.7 (%) 4.6 (%)  3.4 (%) -0.4(%) 
GERD (% of GDP) 
4.17 
(%) 
3.97 (%) 
3.97 
(%) 
 4.0 (%) 
2.06 
(%) 
GERD (euro per capita) 1,142 1,143 1,217 1,252 525 
GBAORD - Total R&D appropriations (€ million) 1,187 1,205 1,276 1,352  
86,309.4
97 
 
R&D  funded by Business Enterprise Sector (% of 
GDP) 
1.56 
(%) 
1.45 (%)    
1.12(201
1) 
R&D performed by HEIs  (% of GERD) 
13.4 
(%) 
13.6 (%) 13.0 (%)  12.6(%) 24(%) 
R&D performed by Government Sector (% of 
GERD) 
1.9 (%) 2.0 (%) 1.9 (%) 1.8 (%) 12(%) 
R&D performed by Business Enterprise Sector (% 
of GERD) 
83.5 
(%) 
83.2 (%) 
84.0 
(%) 
 84.5 
(%) 
63(%) 
Share of competitive vs. institutional public 
funding for R&D  
 39.0 
(%) 
 37.6 
(%) 
 37.8 
(%) 
   
Employment in high- and medium-high-
technology manufacturing sectors as share of total 
employment  
 4.5 
(%) 
4.4 (%)  4.4 (%) 4.3 (%)  
 
The global economic crisis has had a mild impact on R&D funding in Israel as can be seen in the 
table above. GERD, measured as a percentage of GDP, has been in constant decline, falling 
from 4.17% in 2009 to 3.93% in 2012, despite a marked increase in government expenditure 
(GBOARD). This highlights the very high exposure of the research and innovation system to 
global financial conditions, which stems from the very high share of business in funding R&D.  
Total GERD figures relate only to civilian R&D, as there are no unclassified data on the total 
expenditure of the large defence related R&D system. The government has never set out specific 
targets for R&D expenditure, and is unlikely to do so in the future. 
 
The contribution of the business sector to the funding of R&D, keeps on rising, with its share of 
GERD reaching 84.5% in 2012. These levels, although normal for Israel, are surprisingly high, 
especially when compared with the EU 2012 average, where BERD contributes to 63% of the 
GERD. 
According to provisional estimates8, in 2012 national expenditure on civilian R&D, at constant 
prices, increased by 5.3%, following increases of 3.8% in 2011 and of 1.3% in 2010 (See Figure 
1). The increase in the expenditure on R&D performed in the business sector in 2012 mainly 
reflects an increase of 7.5%, at constant prices, in software companies, following an increase of 
4.0% in 2011, and an increase of 5.8% in R&D companies (including start-up companies, 
international R&D centres, technological incubators and research institutes), following an 
                                                 
7 Source for the Israeli data: Central Bureau of Statistics for Israeli data. The EU average comes from Eurostat 
(provided by IPTS December 2013) 
8 Data provided through personal contact with the Israeli Central Bureau of Statistics (December 2013)  
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increase of 5.0% in 2011.  In manufacturing industries the expenditure increased by 5.1% in 
2012, following an increase of 1.6% in 2011.    
The Government sector's expenditure on R&D decreased by 2.3% in 2012, after an increase of 
3.4% in 2011 and a decrease of 3.3% in 2010. The assignment of funding by the public sector 
does not seem to be keeping pace with economic growth. In Higher education institutions, R&D 
expenditures increased by 2.6% in 2012, following an increase of 1.0% in 2011. The proportion 
of contribution to GERD by Higher Education Institutions (HEI) has shown a slow down due 
to budget cuts.  The expenditure in private non-profit institutions increased by 5.4% in 2012, 
following an identical increase in 2011.   
 
In 2012, the ratio of BERD to GDP in Israel was twice the EU average, at 3.51%, although this 
is a lower proportion than in 2009 (3,58%). However, it seems to have recovered from the 
situation of 2010 (3.44%). In general, though, funding from the private sector has been relatively 
unaffected by the global crisis. 
 
 
 
2.2.2. Funding mechanisms 
2.2.2.1 Competitive vs. institutional public funding 
 
According to the data provided by the CBS in Israel9, competitive funding was 37.8 % of the 
total institutional public funding in the 2011 budget. This represents a mild increase after 2010, 
but still not reaching the 2009 level of 39%. A large proportion of the competitive funding is 
awarded by the Israel Science Foundation (ISF), the predominant source of competitive grants 
funding basic research in Israel. With an annual budget of roughly €47 m, ISF funds more than 
1,300 grants a year, providing 2/3 of all such funding in the country. ISF’s funds are mostly 
(96%) provided by the Government of Israel via the Planning and Budgeting Committee 
(VATAT) of the Israel Council of Higher Education (CHE).  
 
                                                 
9 Data provided through personal contact with the Israeli Central Bureau of Statistics (December 2013) 
Figure 1. Evolution of R&D 2012, by Operating Sector (CBS data). 
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Funding for universities is slated to increase annually by 30% over the course of VATAT plan 
while appropriations for the ISF will nearly double. In 2012, the total budget for Higher 
Education was € 8.2 bn. But the proportions between block and competitive funding are unlikely 
to change to any significant degree because the share of total university funding earmarked for 
research, as opposed to teaching, is increasing from about 40% to 50%. 
 
2.2.2.2 Government direct vs indirect R&D funding  
 
Most R&D support is through direct funding by the OCS. In 2012, after all the additions, the 
total budget for OCS was €312 m. A large part of the OCS budget is predicated on co-financing 
by the private sector, ranging from 50-70% co-financing by the private sector in R&D Fund 
grants to 15% co-financing in the incubator programme. 
 
2.2.3 Thematic versus generic funding 
 
The I-CORE programme could be considered a form of thematic funding. Besides the I-CORE 
programme, the Agriculture Ministry funds thematic research with a budget of about €75m and 
there are also some relatively small thematic research programmes run by the Ministry of Science 
and Technology. 
 
Most of the thematic civilian research in Israel is carried out with funding from the Seventh 
Framework Programme (FP7), which is of central importance to the Israeli R&D system. In 
2010, before the beginning of the Vatat six-year plan, FP7 funding of university based research 
was actually higher than the competitive funds from the ISF. This proportion is likely to change 
over the next six years as the ISF budget grows, but the Framework Programmes will remain of 
central importance to the national research system. 
 
2.3 Research and Innovation system changes 
 
National expenditure on civilian R&D, at current prices, amounted to €7.8 billion in 2012, 
constituting 4.0% of GDP. According to provisional estimates, in 2012, national expenditure on 
civilian R&D, at constant prices, increased by 5.3%. This followed increases of 3.8% in 2011 and 
1.3% in 2010. The Government sector's expenditure on R&D decreased by 2.3% in 2012, after 
an increase of 3.4% in 2011 and a decrease of 3.3% in 2010. In higher education institutions, 
R&D expenditures increased by 2.6% in 2012, following an increase of 1.0% in 2011. 
 
Following their announcement at the Chief Scientist's Annual Conference for Research and 
Development held on 3 May 2012, in the Ministery of Economy, a number of new programmes 
have subsequently been launched by the Office of the Chief Scientist (OCS) and are now fully 
operational. These include:  
 
A new early stage technology programme created as a response to a decline in early stage 
investment.  The OCS already devotes a large part of its budget to supporting seed ventures, but 
the sector has had an unusually hard time raising funds because of the global economic 
environment. The new programme will be designed to leverage private capital invested in seed 
companies. The OCS plans the creation of a dedicated post for supervising it. 
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 Kamin, part of the pre-competitive and long term programmes, is intended to promote applied 
research and provide an additional bridge between basic and applied research for those not yet 
ready for commercial investment.  It is intended to encourage academics to pursue research in 
areas of potential commercial interest. Although managed by the OCS’ Magnet Organization it is 
launched in coordination with the Council of Higher Education and the Finance Ministry. 
 
Tzatam is a grant programme for the purchase of R&D equipment intended for experienced 
companies specializing in providing research services in the field of life sciences. €7.2 m. has 
been allocated for the project, over a three year period. An additional €7.2 m. has been allocated 
specifically for stem-cell research equipment.  Tzatam is a TELEM instrument. TELEM is a 
voluntary partnership between the four organizations that support R&D in Israel: Ministry of 
Economy, the OCS of the Ministry of Science and Technology, the VATAT and the Ministry of 
Finance. 
 
Meimad is a collaborative programme to promote new ideas and new technologies that can serve 
both commercial applications and military needs. It is launched between the Ministry of 
Defence, the OCS and the Ministry of Finance. 
 
Since the new government took power, discussions about new innovation policy initiatives are 
being held. However according to information from the OCS, there is, at the time of writing, 
nothing formalised.  
2.4 Recent Policy developments  
 
The list of R&D incentives in Israel was published by the Ministry of Industry, Trade and 
Labour in 2012. The document structures the Domestic R&D incentives in blocks10, and some 
new programmes have been introduced in the 2012 update of the document:  
 
 Competitive R&D:  
KIDMA programme: As the Internet plays an increasingly significant role in every life aspect, 
cyber threats rapidly become more complex and challenging, and their global influence increases. 
This raises the threshold for successfully developing adequate protection systems. Israel’s unique 
advantages and leading global position in the fields of information security, computer security 
and communications security, make it a prominent player in the field of Cyber Defence. 
 
The government, wishing to maintain and enhance Israel’s abilities is this sector, issued Decision 
3611 in mid-2011, calling for “The Advancement of National Capabilities in the Field of Cyber 
Security”. Following this Decision, a programme has been devised by the Office of The Chief 
Scientist (OCS) and the Israeli National Cyber Bureau (INCB), jointly allocating €15,5 m. to 
promote the development of advanced cyber defence solutions and establish cyber security 
knowledge centres. The Programme will be executed through existing OCS Program (R&D fund 
track and the Incubator programme). 
 
R&D in Space Technologies. Israel has knowledge and development capabilities in many areas 
in the field of space technology. Due to the technological complexity of the space environment, 
                                                 
10 (OCS 2012) 
(For a discussion of this document see (Fisher, Eilam, and Garcia-Torres 2012))  
 
  14 
development of systems and assemblies which could function in space involves high 
technological risk, as well as high development and production costs. 
 
In order to respond to these unique market conditions, the Ministry of Science and Technology 
and The Office of Chief Scientist (OCS) in the Ministry of Industry, Trade and Labour have 
jointly initiated a dedicated programme encouraging research and development in various space 
technologies. 
 
Companies eligible for this track include those developing: products to be installed in satellites or 
in earth stations, products designated for the reception or transmission of data from satellites, 
instruments designed for testing and calibration and equipment to be installed in satellites or 
relating to their operation, including adjustment of satellite versions for export. An approved 
project may receive government funding for up to 36 months, subject to compliance with pre-
determined milestones and in accordance with the approved business plan. Overall government 
funding per project shall not exceed €4 m. 
 
 Pre seed and Seed Programmes.  
Technology-based industrial incubators support the ongoing operations of start-up companies in 
order to lead them toward commercialization and market penetration. For a period of two to 
three years, the programme provides companies whose projects were approved by the 
Incubators Committee with full financial support (€400,000 of which 50 percent is granted by 
the government and 50 percent is invested by the incubator), payable only upon generation of 
sales, in the form of 3% of the revenues annually. 
 
Licensees. The Technological Incubators programme has recently undergone a substantial 
reform: the Incubators’ private-sector licensees, who own and operate the incubator, now 
undergo a competitive selection process, opening up the investment opportunity to many new 
actors and making sure the early stage community is constantly at its best. The path is quite 
lucrative for the private investor –having only to invest 15% of the project funding, while 
receiving up to 50% of the ownership of the incubated companies. The licensee can be a foreign 
company. 
 
Alternative Fuels for Transportation  
 
In 2011 the Government of Israel issued a resolution to carry out a national programme 
encouraging the development of technologies to reduce global consumption of petroleum-based 
fuels and boost the development of knowledge-based industries in the field of alternative fuels 
for transportation. The government resolution entailed the creation of an investment 
encouragement programme in said field. 
 
The objective of this new programme is to encourage investments in Israeli companies 
specializing in the development and implementation of technologies in the field of alternative 
fuels for transportation. The government has designated an overall budget of €78 m. to be 
utilized by 2020. 
 
Reduction of greenhouse emissions 
 
In 2010, the Government of Israel launched a national programme for the reduction of 
greenhouse gas emissions. Through this programme, the government aims to reduce Israel’s 
greenhouse gas emissions by 20%, compared to a «business as usual» scenario, within ten years. 
To do so, an investment support mechanism has been established to encourage the installation 
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of cleaner and less polluting systems, by offering a subsidy of up to 20% of the cost of the 
project, up to a ceiling of €1,3 m. 
 
 Pre-competitive and long term R&D programmes 
MAGNET (the acronym in Hebrew for Generic Pre-Competitive R&D) encourages 
collaboration among industrial companies, and between the companies and researchers from 
academic institutions, through several instruments that deal with innovative technologies. These 
instruments seek to develop Israel's industrial infrastructure by supporting the R&D activities 
and sharing technological knowledge among the participants. MAGNET works through the 
formation of consortia composed of industrial companies and academic institutions, in order to 
jointly develop generic, pre-competitive technologies. The duration of a MAGNET consortium 
is 3-5 years. Grants are up to 66% of the approved budget for industry and up to 80% for 
academic institutions. 
 
Nofar 
 
NOFAR is designed to bridge the gap between know-how within academia and the needs of the 
industry. It does so by encouraging the support of applied academic research activity by an 
industrial company. The academic research group gains better understanding of the market’s 
needs and tendencies, while the company taps into ground-breaking discoveries in its field of 
activity. The program supports applied academic research in the following technological areas: 
biotechnology, nanotechnology, medical devices and storage of water and energy. 
 
The project’s budget is up to € 97,000 for a period of 15 months. Grants cover up to 90 percent 
of the approved budget, to be complemented by the industrial company associated with the 
project. No royalty payments are mandated. International technology companies are invited to 
connect with an Israeli academic research institute and take part in the programme. 
 
Nanotechnology. 
 
From 2005 to 2012, six nanotechnology academic research centres have been founded and put 
into operation in Israel. These six centres were funded by collaborative private and public 
resources and have collectively received a total budget of € 75,500 m. 
 
A follow-up programme was implemented in 2012, for the next four years, the main goal of 
which is to establish a strong Nanotechnology industry by transferring technologies from 
academia to industry and by creating a pool of skilled Ph.D. and an M.Sc. graduates in Nano-
science. 
 
Isragrid 
 
The goal of this programme is to enable efficient e-Science research in various fields by 
providing production e-Infrastructure that takes advantage of Grid and Cloud computing 
technologies. Isragrid offers the Industry access to Compute/Data resources via EGI (European 
Grid Infrastructure), user support and training. 
 
2.5 Recent evaluations, consultations, foresight exercises 
 
So far, Israel has never had formalized research or innovation policies in the sense of producing 
policy documents that lay out long term strategies for the entire system with strategic goals and 
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quantitative targets. Until fairly recently, research and innovation were not even considered by 
the same department in the Finance Ministry, and coordination between the two policy fields 
was on an ad hoc basis. 
 
The level of coordination has improved to a certain degree during the past four years but 
functionally, research and innovation policies are still considered separately. Research policy is 
made and enacted by the Council of Higher Education through its Planning and Budgetary 
Committee, commonly known by its Hebrew acronym, Vatat, while innovation policy is 
formulated and implemented by the OCS in the Industry Ministry. 
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3. PERFORMANCE OF THE NATIONAL 
RESEARCH AND INNOVATION SYSTEM 
 
 
New doctorate graduates (ISCED 6) per 1000 population aged 25-34 
1.4% for 2012 
Percentage population aged 25-64 having completed tertiary education 
 
46% for 2011 
Open, excellent and attractive research systems 
 
 
International scientific co-publications per million population 
 
994.95 for 2012 
(source: scopus) 
Scientific publications among the top 10% most cited publications worldwide as % of total scientific 
publications of the country 
 
n.a. 
Finance and support 
 
 
R&D expenditure in the public sector as % of GDP 0.54% for 2012 
Public Funding for innovation (innovation vouchers, venture/seed capital, access to finance granted by the 
public sector to innovative companies) 
€186,7 m, for 2011 
FIRM ACTIVITIES 
 
 
R&D expenditure in the business sector as % of GDP 33.2% for 2012 
Venture capital and seed capital as % of GDP na 
Linkages & entrepreneurship 
 
 
Public-private co-publications per million population No data 
Intellectual assets  
PCT patents applications per billion GDP (in PPS€) 
0.047% by 
Application date and 
Inventors country 
residence for 2011 
(source: OECD-
STAT) 
PCT patents applications in societal challenges per billion GDP (in PPS€) (climate change mitigation; health) No data 
OUTPUTS  
Economic effects  
Medium and high-tech product exports as % total product exports 64% for 2012 
Knowledge-intensive services exports as % total service exports na 
License and patent revenues from abroad as % of GDP 0.05% for 2011 
 
Israel is a highly knowledge-intensive country. It has a strong and dynamic business sector and 
has achieved excellence in scientific and technical education and research. This has led to high 
levels of technological entrepreneurship and start-ups. The economy is very knowledge-intensive 
with high- and medium-tech products contributing significantly to the trade balance. The main 
strengths of Israel are its high research intensity, mainly due to very high business expenditure on 
R&D, and its patenting activity. According to the Competiveness Report 2013 (European 
Commission 2013), the number of business researchers (head count) per thousand labour force 
is more than four times the EU average (14.8 compared to 3.4, in 2009) and the country has 
been successful in attracting foreign investment for research and innovation. Israel is ranked 
second (to the United States) worldwide in terms of venture capital availability, thus ensuring the 
right conditions for highly innovative small companies across all sectors. 
 
As commented in the section 1, Israel is well above the EU average for the majority of the R&I 
indicators. Indeed, Israel’s overall level of innovation performance places it among the group of 
European “innovation leaders”. Only Sweden, Switzerland and Finland show higher levels of 
innovation performance. PCT patent applications per billion GDP are three times higher than 
the EU average, a remarkable difference.   
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3.1 Structural challenges of the national R&I system 
 
The Israeli research and innovation system faces three deep structural challenges that derive both 
from internal factors and from shifts in the global marketplace. These are long term challenges 
that predate the global economic crisis that started in 2008, even though the crisis may have 
highlighted their urgency, and they require the kind of long term responses that helped the Israeli 
research and innovation systems excel in the previous two decades. 
  
At least two of the challenges stem partly from this same success. The ability to attract private 
investment in R&D is what enabled Israel to be the top scorer in the Innovation Union 
scoreboard of R&D intensity11, but that same success made for underinvestment in other factors 
that also contributed significantly to the success. Like most structural challenges, these challenges 
are extensively interrelated and touch on many other issues of concern to policymakers, but they 
are distinct enough to outline separately as follows: 
 
1. Making up for the "lost decade" 
Investments in Israeli higher education and research essentially stagnated during the first decade 
of the century. From 2000 to 2010 budgets effectively declined compared to the growth in 
population. By the middle of the decade, investment per student had declined by 9% compared 
to 199512 and the average age of faculty in exact science departments was over 55. Investment in 
research infrastructures also fell behind, forcing universities to rely mainly on donations.  
 
In output terms, the first results could be seen by the end of the decade in the decline in the 
country's share of world scientific publications which declined from 1.1% in 2000 to 0.9% in 
200913, proportionately a radical decrease for a small country highly dependent on research and 
innovation. As far as citation impact is concerned, the decline was less acute, from 12th to 13th 
place worldwide according to a study14 of Israeli scientists' publications. The lower drop in 
citation index rankings was attributed to the impact of papers of older researchers many of 
whom have reached retirement age. 
 
As a result of this stagnation brain drain became an acute problem.  At the end of 2013, there are 
no up to date definitive figures on brain drain but a study published in 200715 showed that 
Israelis with tertiary degrees had proportionately the highest rate of emigration to the US in the 
world. In the higher tiers of scientific research this has become such a major problem that it has 
become a defining policy priority. 
 
 
2. Heavy Reliance on ICT 
The Israeli economy is heavily reliant on ICT based exports and clusters of industries based on a 
deep pool of talent that stretches from academe to small ICT based start-ups. The Israeli 
economy offers a fascinating illustration of extraordinary success in innovation, particularly in 
Information and Communications Technologies (ICT), which came largely as a result of a 
concerted, long term strategy of government support for commercial R&D, which levered the 
potential of a highly skilled labour force. Yet, the benefits from the rapid growth of the High 
                                                 
11 European Commission 2011, page 49 
12 Fisher and Eilam 2009 
13  European Commission 2011, page 137 
14 Samuel Neaman Institute 2011 
15  Gould and Moav 2007 
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Tech sector eluded the rest of the economy, thus giving rise to a “dual economy”: a high rate of 
growth for ICT and a mediocre growth rate for the economy as a whole. (Trajtenberg 2006) 
 
The success of this industry is what enabled Israeli R&D based industries to attract substantial 
investment by business in ICT based industries, and this in turn was one of the reasons for the 
reduction of total government support of business based R&D by 36.3%16 compared to inflation 
adjusted prices of the year 2000.  
 
Policymakers have been aware of this situation for years, and have been encouraging Israeli 
industry to diversify through a variety of measures and initiatives. Yet they face a challenging 
dilemma: an in depth study17 has proven that government support of mainly ICT based 
industries is critical for economic growth in a highly competitive world, even though the majority 
of funding for innovation comes from the business sector. This means that a decision to divert a 
major part of the government resources intended to support industrial R&D to other new fields 
would cause extensive economic damage. Technology based exports, predominantly based on 
ICT, account for close to half of Israeli exports. There are no data on exactly what percentage of 
these exports are based on government support programmes, but by definition, government 
support is extended to the riskiest R&D ventures, those that give Israeli ICT exporters their 
competitive edge. Hence, diversion of resources from ICT would deprive Israeli industry of an 
important element of its competitive capacity. 
 
Yet not diversifying is also not seen as a good long range option (Trajtenberg 2006). The overall 
returns on the heavily ICT based Israeli venture capital industry have been disappointing during 
the past decade. Since a major part of the Israeli innovation system is predicated on creating new 
ICT companies this is a strong indicator showing that the innovation system needs new engines 
of growth.  
 
During the past decade, the government largely abandoned the field of thematic university based 
research in all civilian fields except for agriculture and most of the thematic research conducted 
in Israeli universities is through the country's participation in the EU Framework Programmes. 
Extensive thematic research is carried out is the country's large and classified defence R&D 
system, and there is anecdotal evidence18 of major spill-over effects to the civilian based ICT 
innovation system. This successful example shows that developing new areas of expertise 
requires not only extensive human and physical infrastructures, but also a judicious mix between 
thematic academic research and project-oriented R&D.  Hence, the challenge to develop non-
ICT based innovative industries must be cast not only in terms of the industrial policy, which is 
managed by the Office of the Chief Scientist in the Ministry of Economy (OCS), but also in 
terms of research policy managed by Vatat (The Planning and Budgeting Committee of the 
council for Higher Education, and by the Israeli Science Foundation). 
 
3. Precarious VC Environment 
Venture Capital is an essential part of the Israeli innovation system. To put things in proportion, 
the total annual investment by VCs in Israeli technology start-ups during the past decade has 
usually been at least four times higher than the total government budget to support innovation in 
all firms from start-ups to major corporations. 
 
                                                 
16 Statement by Avi Hasson, Chief Scientist in the Ministry of Industry, Trade and Employment, October 2011 
17 (Lach, Wasserteil., and Prizant 2008) 
18 (Eilam 2011) 
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According to the latest data from IVC-Online19, during 2013 a record was reached with 662 
Israeli high-tech companies attracting €1.78 bn. (the most raised in the last 10 years). Three 
hundred and ninety five VC- backed deals attracted €1,33 bn. or 74 percent of the total amount 
raised in 2013, just above the 72 percent of 2012, but well lower than the 83 and 87 percent 
reached in 2011 and 2010, respectively.  
 
The average company financing round in 2013 was € 2.70 m, near to the € 2.63 m of 2012 and 
the10-year € 2.77 m average. The average financing round of VC-backed deals reached € 3.35 m, 
compared with € 2.06 m in 2012. 
 
The underlying data may give greater cause for concern. Investments by Israeli VCs now account 
for only 25-30% of total VC investment in Israel, with the rest coming from foreign funds. This 
means that investments at the seed stage, which are typically handled by Israeli VCs and not their 
foreign counterparts, are in jeopardy. In addition, the funds from foreign VC funds are not 
committed a priori to investments in Israeli firms and could dry up at the next instance of the 
global financial crisis or be moved to more promising pastures in the Far East.  
 
The Israeli VC industry has become part of the system, and it diminishment could have a severe 
impact on company formation and the rest of the Israeli innovation system, thus presenting 
government with a major challenge. 
 
3.2 Meeting structural challenges20 
 
Two of the three challenges outlined above, the quality of university research and the precarious 
status of Israeli venture capital, have been addressed by actions intended to directly mitigate the 
problems in the country's research and innovation systems. The third challenge, the need to 
diversify the ICT-centric technology sector, has been addressed by a variety of measures, but this 
is a long term and complex challenge that defies simple solutions. 
 
It is far too early to assess the effectiveness of the six-year Vatat plan (2011-2017) and the I-
CORE programme. The first indicators of success will be the number of new researchers 
retained by universities and the number of researchers who return to Israel to join I-CORE 
programmes.21 However, the real tests of the programme will be in general academic quality as 
measured both by bibliometric and other indicators, and by the commercial technologies that 
derive from this basic research. Both of these will take a long time to materialize. There has been 
some criticism in academic circles of the I-CORE programmes with academics saying that 
preferred status of I-CORE centres will be at the expense of other academic researchers. But 
there is so far little evidence to support this claim. In general, the response to the challenge of 
the "lost decade" seems comprehensive and integrative, especially since it does not seek to turn 
the wheel back but to create a research environment suited to the conditions of the 21st century. 
 
As reported above, the large venture capital sums attracted by Israeli high-tech firms (€1.78 bn. 
in 2013) can be interpreted as a positive reaction toward the government policy from the Israeli 
VC industry. However, the effectiveness of the response depends on so many extraneous factors 
that it is hard to judge on its own merits. Israeli institutional investors, like their colleagues in 
other countries, are judged by harsh criteria such as performance per quarter. The decision of 
                                                 
19www.ivc-online.com/Portals/0/RC/Survey/IVC_Q4-13_Survey_PR-final.pd 
20 For a deeper analysis see previous editions of this report (Fisher, Eilam, and Garcia-Torres 2012; Fisher and Eilam 2011) 
21 At the end of 2013 there is still no information on the effectiveness of those plans. 
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whether to lock up capital for seven to 10 years because of the government's commitment to 
underwrite part of the risk depends to a large extent as much on current market conditions as on 
strategic considerations about the composition of each investor's portfolio. If Israeli investors 
are choosing to enter the programme, this is only one part of each fund management company's 
struggle. They then have to persuade investors abroad, who should make up the majority of each 
limited partnership to invest in their fund despite the current tumultuous state of capital markets.  
 
The challenge of diversification beyond ICT is both more complex and more intriguing. Proof 
that it is achievable can be seen in the development during the past decade of a substantial 
cluster of Israeli companies in the field of medical devices, which is based on the skills and 
entrepreneurial drive of researchers and technologists from a broad range of fields ranging from 
medicine to ICT. However, even if the various measures promulgated and enacted by the OCS 
from biotechnology through nanotechnology to cleantech are successful, and if the I-CORE 
programme does indeed lead to the development of skills needed for the next generation of 
technologies, this might not be enough. The various clusters of Israeli companies in ICT are 
predicated on two additional conditions. The first is markets in a state of rapid growth in which 
relatively small Israeli companies can make their mark. The second is the existence of a financial 
ecosystem that can develop these companies. Even if these issues have not been resolved now, it 
is clear that various government initiatives, if seen in concert, are trying to address the 
complexities of this problem. 
 
Table 2: Policy measures and assessments 
 
Challenges 
Policy measures/actions Assessment in terms of appropriateness, efficiency and 
effectiveness 
Redressing 
the "lost 
decade" in 
academic 
research 
1. Six-year Vatat plan 
increasing research budgets 
and retaining more 
researchers 
2. I-CORE programmes for 
centres of research excellence 
The programme to repair and renew academic research 
appears to be both appropriate and comprehensive, but it is 
too early to appraise its effectiveness 
Over reliance 
on ICT-based 
innovation 
1. OCS programmes 
encouraging R&D in new 
fields including traditional 
industry. 
2. Government participation 
in dedicated biotech VC 
fund. 
OCS programmes are generally effective in addressing their 
immediate target. However the OCS cannot devote more of its 
limited budget devoted to non-ICT commercial R&D because 
the funds are needed by proven generators of jobs and wealth 
in ICT. The drive to diversify must go far beyond the 
immediate target of reducing the risk of commercial R&D. If 
the I-CORE programme does indeed produce both the 
knowledge and human skills needed to develop new fields, this 
is only part of the infrastructure needed for diversification. 
Precarious 
state of 
Venture 
Capital 
Government measure to 
insure 25% of the risk of 
Israeli institutional investors 
who join funds as limited 
partners 
It is still early and difficult to assess but there is a positive 
reaction from the Israeli VC industry in terms of the volume 
of funds raised.  
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4. NATIONAL PROGRESS IN INNOVATION 
UNION KEY POLICY ACTIONS  
 
The first round of negotiation between the European Union and Israel on Israel’s participation 
in Horizon 2020 took place during August 2013.  Terms and conditions of such negotiations, 
which include the financial contribution of a non-EU participant to Horizon 2020, needed to be 
agreed between EU and Israel. To that end the Union and Israel engaged in negotiations on a 
Memorandum of Understanding. The first round of negotiations was limited to exploratory talks 
on technical and financial aspects of the Horizon 2020.  During September, in the second round 
of negotiations, discussions started on the territorial scope of the future Memorandum and the 
application of the Guideline of eligibility of Israel entities and their activities in areas outside the 
1967 line. The decision affect grants, prizes and financial instruments funded by EU form 2014 
onwards. 
 
Israel has taken part in the Framework Programmes since 1996, and is expected to invest €600 
m. over the next seven years in Horizon 2020. It is also expected to receive €900 m. in grants 
and investments. In December 2013, Israel and the EU have come to a decisive agreement 
guaranteeing the former's eligibility to Horizon 2020 funding. After months of intense 
negotiations, EU High Commissioner Catherine Ashton and Israeli Justice Minister Tzipi Livni 
reached an agreement. The agreement fully respects the EU's financial requirements while at the 
same time respecting Israel's political sensitivities and preserving its principled positions 
 
4.1 Strengthening the knowledge base and reducing fragmentation 
 
Promoting excellence in education and skills development 
 
In 200922 there were some 54,400 researchers in Israel23, 83% in the business sector and the 
remainder in the academic sector. This breakdown matches the breakdown of R&D financing in 
Israel, with some 80% coming from the business sector. 
  
After increasing by 18.5% between 2005 and 2007 (the increase was entirely in the private 
sector), the number of researchers did not increase at all between 2007 and 2009. This was 
apparently the result of the global recession, which also led to a reduction in the volume of 
business sector innovation financing. The fact that the number of researchers in the academic 
sector remained unchanged throughout 2005-2009 – together with the relatively low share of 
researchers in this sector – more than hints at a supply problem with researchers at Israel's 
universities.  
 
During 2013, Israel continued to lay emphasis on its main challenge in the area of flows of 
researchers, particularly in the academic sector: to attract researchers – both Israelis working 
abroad and foreign researchers – to conduct research in Israel. The policy vehicle implemented 
to meet this challenge was the establishment of I-CORE, as part of a new six-year plan which 
will offer significantly increased budgets for higher education, both for teaching and for 
                                                 
22 The most recent year for which data are available at December 2013, more updated data have been promised by the CBS in the 
near future. 
23 Data from the Central Bureau of Statistics; parallel data published in the ERAWATCH Country Report 2010 for Israel differ 
due to the inclusion of non-research staff in the R&D sector. 
  23 
research: the plan including the I-CORE initiative was presented to the Government of Israel in 
March 2010 and its implementation began in 2011. The total six-year budget for the 
establishment of the 16 Centres is some €320 m out of a total budget for the plan of €1.3 bn24. 
 
The main goals of I-CORE are to reinforce excellence in Israeli universities, improve their 
competitive position globally and reverse the brain drain by attracting back to Israel senior 
researchers who have worked abroad for an extended period. 
 
During 2011, the first four centres established were all in scientific and technological areas – the 
Molecular Basis of Human Diseases, Cognitive Science, Computers Sciences and Alternative 
Energy Sources. The second phase of the programme was implemented in 2012 and 11 new 
centres were established covering a wider range of disciplines: 4 will engage in research in the 
Social Sciences and Humanities and seven in Exact Sciences, Engineering, Life Sciences and 
Medicine. The aim is to establish the centres in the coming years. More specifically, the new 
centres are focused on:  Jewish Culture, Education and New Information Society, Legal Studies, 
Mass Trauma, Quantum Universe, Light and Matter, Astrophysics, RNA Gene Regulation, 
Biophysics, Environmental Change, and Dynamic Processes in Living Systems. 
The second wave represents another major step in the Centres of Excellence programme and is a 
main pillar in the Multi-Year Reform Plan in Higher Education - a programme aimed at 
fundamentally strengthening the long term positioning of Israel's academic research and its 
stature among leading researchers in Israel and abroad. 
 
 
Research Infrastructures  
 
In the last years there has been no specific initiative concerning financial commitments for the 
construction and operation of ESFRI roadmap. However it is important to comment that Israel 
participates in ESFRI as an associated country state.  
 
Israel as a non-member state has no RI obligations. However it is very aware of the Research 
Infrastructures needs of the country. These are tackled through the VATAT plan and by the 
institution of the I-Core centres of excellence. 
4.2 Getting good ideas to market 
 
Improving access to finance 
 
MATIMOP is a governmental non-profit organization that aims to promote the development of 
advanced technologies in Israel and to create fruitful international partnerships through industrial 
cooperation and joint ventures. It acts on behalf of the OCS as the national agency in charge of 
encouraging and assisting participation of Israeli enterprises in international bilateral or multi-
lateral cooperation programmes for industrial R&D. MATIMOP implements most bilateral 
R&D cooperation agreements on behalf of the OCS and thus serves as a contact point for 
various agreements.  It is the national coordinator of the Enterprise Europe Network (EEN) 
centre in Israel. The Enterprise Europe Network is comprised of about 600 partner 
organizations in more than 40 countries in Europe, North America, Latin America and Asia 
Pacific promoting competitiveness and innovation services to SMEs. EEN offers a "one-stop 
shop" to meet all the information needs of SMEs and companies in and around Europe The 
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EEN provides partnering and brokerage services, publication of technology offers and 
technology requests, access to European, national and/or regional support schemes and 
additional services supporting technological partnerships and internationalization of SMEs. It 
exploits the synergies between all support services and help desks for European businesses. 
 
The MAGNETON programme promotes technology transfer from academia to industry 
through mutual cooperation between an individual company and a specific academic research 
group, in order to reduce the uncertainty before using the technology by the firm in new 
developments.  In 2012, two new initiatives were launched: Nofar, and Meimaid.  Nofar, was 
designed to support applied academic research in specific technological areas (biotechnology, 
nanotechnology, medical devices, water & energy storage), in order to adapt it to relevant 
applications in the industry, and promotes the transfer of these technologies to the industry. 
Meimaid is a collaborative programme between the Ministry of Defense, the OCS at the Ministry 
of Economy and the Ministry of Finance, to jointly promote new ideas and new technologies 
that can serve both commercial applications and military needs. 
 
The transfer of knowledge is also fostered in the incubator programme for firms, where there are 
internal processes dedicated to the diversification of new technological knowledge. Also there is 
a “Users Association" of industrial companies involved in the dissemination and assimilation of 
generic advanced technologies, and the sharing or utilizing common technologies.  
 
 
Protect and enhance the value of intellectual property and boosting creativity 
 
Concerning the protection of intellectual property rights, no recent changes have been 
implemented. Israel, as a small innovative country very much relies on international IPR systems. 
No recent policy changes in this area. 
 
Israel’s IPR was revised in 1967. At that time, as with most advanced nations, Israel was a 
signatory to all major relevant treaties of the World Intellectual Property Organization, including 
the Berne Convention, Paris Convention, and Patent Cooperation Treaty. Israel later joined the 
World Trade Organizations Agreement on Trade-Related Aspects of Intellectual Property Rights 
(TRIPS), and in 1999 developed protections for topographies of integrated circuits.  
 
Throughout its modern history, Israel’s IP regime was in line with that of the most advanced 
nations. Strong reciprocal enforcement of international treaties allowed Israeli firms to effectively 
seek protection in other markets, such as the US and Europe. This cooperation served as a 
backbone for international trade and was an important foundation for the emergence of strong 
innovation capabilities. Without strong IP enforcement and reciprocation, it is doubtful that 
Israel’s high tech development could have taken place. (see Avidor 2011; Pugatch, Teubal, and 
Zlotnick 2010) 
 
Public procurement 
 
Public procurement in Israel relates mostly to the R&D Fund. The R&D Fund is the main 
instrument of The R&D Law. It gives grants to “Approved R&D Programs”, which are 
programmes lasting one or more years, resulting in the development of a new product or in a 
significant improvement to an existing product. The development may also lead to a new 
industrial process or to a significant improvement in an existing industrial process. 
 
A special track is dedicated to traditional industries (industries characterized by relatively low 
investment in R&D). This track offers separate evaluation and discussion for projects. Operated 
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since 2010, there is another special track that supports large companies in establishing their R&D 
centres in Israel's Periphery. It aims to bridge the gap between Israel's centre and its periphery, 
by convincing large companies to locate their R&D centres in areas with less economic growth. 
This creates a mechanism of increased quality employment and economic activity within the 
target geographical areas. 
 
4.3 Working in partnership to address societal challenges 
 
Some Israeli firms and research institutions have already manifested their willingness to 
participate in the European Innovation Partnerships. However, it is still too early to know if they 
will be part of the successful consortia. 
 
4.4 Maximising social and territorial cohesion 
 
There is no explicit national Smart Specialisation Strategy, although the Israeli Government fully 
supports local and regional initiatives towards the development of local strategies. It has shown 
strong support for the development of the peripheral areas versus the more central advanced 
Tel-Aviv/ Jerusalem area. 
 
4.5 International Scientific Cooperation 
 
This point is already covered (see 4.1) the establishment to the 20 I-Core Centres has as one of 
its main goals to attract back top talents from US. 
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5. NATIONAL PROGRESS TOWARDS 
REALISATION OF ERA  
5.1 More effective national research systems 
The increase in research via open national competition in Israel is channeled through two main 
sources, the competitive R&D fund and the VATAT. The competitive R&D fund is the main 
instrument of the R&D law. It gives grants to approved R&D programmes that last one or more 
years, resulting in a new product or process. It is therefore a grant for applied research, given to 
firms and the development may lead to new industrial process or to a significant improvement in 
the R&D.  The planning and Budgeting Committee (VATAT) is the main instrument to finance, 
basic research, i.e. research done by universities. In Israel they remain very autonomous, once 
they are given their budget they are at liberty to decide how to use this budget within the 
university – for teaching or for research. The financing is allocated by VATAT according a 
model in which the universities´ achievements both in teaching and research are measured.  
5.2 Optimal transnational co-operation and competition 
Israel has a long history of joint R&D activity with countries abroad – both in the EU and other 
countries – in various forms and frameworks. This activity, which is significant and expanding, is 
not the result of policy actions at the national level, even though some of the activity is under the 
supervision of government agencies such as the Ministry of Science and Technology 
(www.most.gov.il). Most of the joint R&D activity is in the form of bilateral agreements between 
Israel and a single country. In the area of industrial R&D, such agreements are most often 
arrived at through MATIMOP. 
5.3 An open labour market for researchers 
In 2013, Israel continued to lay emphasis on its main challenge in the area of flows of 
researchers, particularly in the academic sector: to attract researchers – both Israelis working 
abroad and foreign researchers – to do their research in Israel. The policy vehicle implemented 
to meet this challenge was the establishment of Excellence Centres (known by the generic name 
I-CORE – Israeli Centres of Research Excellence) as part of a new six-year plan which will offer 
significantly increased budgets for higher education, both for teaching and for research. The 
main goals of I-CORE are to reinforce excellence in Israeli universities, improve their 
competitive position globally and reverse the brain drain by attracting back to Israel senior 
researchers who have worked abroad for an extended period. 
 
5.4 Gender equality and gender mainstreaming in research  
In general, the preparation of women, via higher education, for careers in Israel is similar to that 
in other developed countries, where more than half of the student population is female: in Israel, 
this is true also for PhD. students. Even though the overall picture here seems to point to equal 
opportunities for males and females to become researchers in Israel no clear conclusions can be 
drawn about women's research opportunities. There are certainly no policy regulations in place 
to correct any possibilities of discrimination against women in achieving research positions or to 
promote equal gender representation in academic and research committees, boards and 
governing bodies. There are also no regulations to guarantee the progression of female 
researchers with equal opportunities to their male counterparts, after career breaks. 
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5.5 Optimal circulation, access to and transfer of scientific knowledge 
including via digital ERA  
Even though the importance of knowledge transfer between the academic sector, public research 
organisations (PRO's) and industry is recognized – and even talked about – in Israel, there are no 
national guidelines to promote knowledge transfer, no Industrial Liaison Offices in universities 
and no support measures in place at the national level to facilitate the creation of university spin-
offs and to attract venture capital and business angels. Each university has its own rules 
concerned with Intellectual Property created by researchers, and that fact that the government 
funds research does not give it any stake in researchers' IP. 
 
Nevertheless, there is considerable de facto knowledge transfer taking place. All seven research 
universities have highly active technology transfer (TT) companies that specialize in 
commercialising IP developed in the universities25, based on different promotion strategies. 
Some of the universities have turned their TT companies into significant revenue-providers. 
It appears that knowledge transfer works in Israel without national guidance or policy, with the 
partners to the transfer – the developers of technology and the absorbers/appliers/ 
commercialisers – cognisant of the mutual benefits of TT: this approach seems to parallel the 
major share of the business sector in R&D development in general in Israel. 
Nevertheless, mention should be made of government-initiated programmes aimed at 
strengthening the connection between academic R&D and industry.  
 
MAGNET is one such programme (www.magnet.org.il). Operated under the auspices of the 
Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labour (MOITAL), 
consortia of industrial companies and academics work together to support generic pre-
competitive R&D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
25 Yissum at the Hebrew University of Jerusalem (www.yissum.co.il), Ramot at Tel Aviv University 
(www.ramot.org), Yeda R&D at the Weizmann Institute (www.yedarnd.com), Carmel Ltd. at Haifa University 
(www.carmel-ltd.ac.il), T3 Technology Transfer at the Haifa Technion (t3.technion.ac.il), BGN Technologies at 
Ben-Gurion University (web.bgu.ac.il/Eng/BGN1) and the Bar-Ilan R&D Company at Bar-Ilan University. 
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ANNEX 1. PERFORMANCE THE NATIONAL 
AND REGIONAL RESEARCH AND 
INNOVATION SYSTEM 
 
 
Feature  Assessment  Latest developments  
1. Importance of 
the research and 
innovation policy  
 
 
(+) Innovation policy very present in the government and 
very much foster by its ministries. Innovation is a crucial 
concept in Israeli society. Being a small country it is also one 
of its main ways to enhance growth. 
(-) Very fragmented between ministries. Sometime there is 
duplication of programmes addressed to the same target.  
Need for coordination towards the design and 
implementation of innovation policy. 
(+) The Ministry of Finance 
has been increasing its 
involvement in innovation 
policy. Acting as horizontal 
agent coordinating policy 
across all other ministries 
involved in innovation. 
(+) Funding is addressing 
societal challenges. (see 
section 3.3) 
2. Design and 
implementation of 
research and 
innovation policies 
 
(+) The design of Innovation policy is coordinated mostly 
between the Ministry of Education responsible for a six-year 
annual programme (VATAT) and the implementation of the 
I-CORE centers of excellence. The other big agent is the 
Ministry of Industry responsible for the OCS which 
implements the R&D fund, and other R&D programmess 
(see sections 2.3 and 2.4).  
(-) Smart specialization is not directly addressed, although 
regional development of some marginal areas are being 
targeted under some innovation policies (see sections 2.6 
and 4.4) 
(-) No effective monitoring and review system is in place. 
Every 4-5 years the government set up a committee of 
experts to review innovation policy. 
New government, still early 
to say which changes will 
affect the design of 
innovation policy. 
3. Innovation 
policy  
 
(+) The concept of innovation is very much present in the 
government and in the society. Known as the start up 
nation, Israel is well aware of innovation and on its needed 
effect for the well being of the society. 
(+) Being a small country looks at the world as it main 
consumer. Very much export oriented country. However 
policy mostly address supply side. 
(+) In general innovation is 
very present in the policy 
and in the society. 
4. Intensity and 
predictability of 
the public 
investment in 
research and 
innovation  
 
(+) The intensity of R&D being the result of multiannual 
programmes (VATAT, I-Core centres and R&D fund) it is 
predictable. The government expenditures have been 
growing over the last 5 years (See section 2.2).  
(-) The proportion of R&D performed by government is 
very small compared by the R&D performed by firms 
(84,5%). Leave little room for policy intervention. 
(+) Positive evolution, over 
the years there is a constant 
increase on government 
expenditures in R&D.  
(-) In relation to the total 
R&D performed in Israel, 
government expenditures 
have been growing less than 
private expenditures. Less 
share being control by the 
government. 
5. Excellence as a 
key criterion for 
research and 
education policy 
 
(+) Balanced allocation of funding. 37% of competitive 
funding in relation to all government funding. 
(+) Competitive funding is allocated on the basis of 
international recognized criteria.  
(+) A proportion of the budget allocated to universities 
depends on their international publications. 
(+) Most of the experts in 
charge of allocating fund 
have a lot of international 
experience. Very well aware 
of the international 
standards. 
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(-) In general funding is not 
portable outside Israel. 
(-) No deference towards 
increasing the participation 
of women in the society. 
6. Education and 
training systems  
 
(+) The higher education is under the VATAT programme. 
Increasing the amount of money for Universities. 
(+) Israel is known by having an education system that 
foster problem solving and creativity toward memorization 
of concepts. 
(-)Brain drain is considered one of the current problems of 
the country. 
 
 
(+) I- Core centers of 
excellences are trying to 
bring back top scientist and 
revert the brain drain. 
(-) Scarcity of data to 
analyzed the real situation 
of researchers and brain 
drain. 
7. Partnerships 
between higher 
education 
institutes, research 
centres and 
businesses, at 
regional, national 
and international 
level 
 
(+) The incubator programme takes into consideration all 
the process from basic research to marketing and 
commercialization of the finalized product. 
(+) Magnet is a programme designed to increase 
collaboration between private and public agents fostering 
the transfer of knowledge. 
(+)  Knowledge created by university is being transferred 
without much government control, but the number of start 
ups around basic research is a good sign that the transfer is 
taking place successfully. 
(+) Bilateral international agreements are normal on a 
project based. Quite big network. 
 
(+) Normal positive 
evolution. 
8. Framework 
conditions 
promote business 
investment in 
R&D, 
entrepreneurship 
and innovation 
 
(+) The high level of R&D, close to 4% of GDP, is a clear 
sign that the conditions are in the country.  
(+)  VC industry seems to have recovered from the lack of 
capacity to raise funds. 
(-) A high proportion of the BERD and of the VC is in 
foreign hands, leaving the country too exposed to the 
international markets. 
(+) Very positive situation, 
capacity to attract a lot of 
foreign investments. 
(-) The foreign participation 
in R&D and VC is so big in 
relation to the national that 
leave the country in weak 
situation too expose to 
changes in international 
markets. 
9. Public support 
to research and 
innovation in 
businesses is 
simple, easy to 
access, and high 
quality 
 
 
(-) High level of bureaucracy in the government and in 
allocation of funding. 
(-) Although the basic part of the support system does not 
change, new funds and programmes are always being added 
(+) National funding is allocated according to international 
standards. 
 
(-) High level of 
bureaucracy across all the 
government. Difficult to 
change. 
10. The public 
sector itself is a 
driver of 
innovation 
 
 
(+) The government has played always an important role 
supporting firms and helping them to innovate. It always 
played from behind trying to be close to firms need. 
(-) It has never been an innovator itself. 
(-) Data are difficult to access.  
(+) The CBS, main provider 
of data, is going through a 
renovation programme aim 
at providing free data in a 
user friendly platform.  
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ANNEX 2. NATIONAL PROGRESS ON 
INNOVATION UNION COMMITMENTS  
 
 
    Main changes  Brief assessment of progress / 
achievements 
1 Member State 
Strategies for 
Researchers' Training 
and Employment 
Conditions  
No recent changes (+) Use of the principles of charter & code by 
all Universities and Research Institutions. 
(+) In 2012, the EC recognized Technion for 
working within the best practices guidelines of 
the European Charter of Researchers 
4 ERA Framework    
5 Priority European 
Research 
Infrastructures 
 Participation in 
SESAME. New CERN 
project in the middle East 
to build a so-called 
synchrotron 
light source, functioning 
like a giant microscope. 
(2013) 
 (+) Israel is an Associate Member in the pre-
stage to Membership of CERN. Expected to 
become a full member in the near future. 
7 SME Involvement  No recent changes  (+)MATIMOP is the national coordinator of 
the Enterprise Europe Network centre 
in Israel. Provides partnering 
access to European, national and/or regional 
support schemes  
and internationalization of 
SMEs. 
11 Venture Capital Funds  No changes (+) Public VC are organized under the 
TMURA programme.  
(+)Programme to support VC-Backed 
Companies in The Field of 
Alternative Fuels for Transportation 
(-) Although improving the national 
participation of Israel VC is still low, compare 
to the foreign VC. 
13 Review of the State Aid 
Framework 
 No changes   (+)  A range of government departments 
provide advice on state aid regulations. 
14 EU Patent  Not applicable to Israel.   
15 Screening of Regulatory 
Framework 
 No changes  (+) Not the case of Israel, especially related 
to R&D support. 
17 Public Procurement  No changes  (+) Covered mostly by the competitive R&D 
fund.  
(+) Special track of the fund is dedicated to 
innovation in traditional industries. 
(+) Another special track is dedicated for large 
companies, which settle in the peripheral 
areas. 
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20 Open Access  (+) National Bio-bank, a 
collection of human 
biological material. It 
allows researcher to 
analyse data they could 
not use before. (2012) 
 (+) Under Magnet public programme, there is 
a “Users Association” of industrial companies 
involved in the dissemination and assimilation 
of generic advanced technology.  
 
21 Knowledge Transfer -Nofar.  Designed to 
support applied academic 
research in specific 
technological areas, and 
promotes the transfer of 
these technologies to the 
industry. (2012) 
-MEIMAD. A 
collaborative program to 
transfer the use of military 
technology for societal 
applications. (2012) 
 (+) MAGNETON is the programme that 
promotes technology transfer forma academia 
to industry via mutual cooperation between an 
individual company and an academic research 
group. 
(+) In the incubators programme special 
agencies devoted to the transfer of 
technology. 
22 European Knowledge 
Market for Patents and 
Licensing 
Not applicable to Israel.   
23 Safeguarding 
Intellectual Property 
Rights 
 Not applicable to Israel.   
24 Structural Funds and 
Smart Specialisation 
National Institute for 
Biotech in the Negev. 
Technological Centers for 
Water and Renewable 
Energies 
Solutions (2011) 
(+) The special R&D public funded track 
devoted to Large companies settling in 
peripheral areas. 
 
25 Post 2013 Structural 
Fund Programmes 
 Summer 2013, tensions in 
the negotiations for Israel 
to continue in the 
Programmes (see section 
5) 
 (-) The future participation of Israel in the 
European Programmes is depending on 
agreements on Israeli borders. 
26 European Social 
Innovation pilot 
 no changes.   
27 Public Sector 
Innovation 
 No recent changes.  (+) In general, Israel supports the 
publications of government data. An example 
is the National Bio-Bank. 
29 European Innovation 
Partnerships 
In 2012 several firms 
expressed willingness to 
participate in at least two 
EIP.  
 Too early to say. 
30 Integrated Policies to 
Attract the Best 
Researchers 
I- CORE programmes (+) Out of the 20 centers included in the I-
CORE programme, 15 have already been 
established.  
31 Scientific Cooperation 
with Third Countries 
No changes.  (+) Organized in form of bilateral 
agreements. Israel has a long list of worldwide 
R&D collaboration agreements. 
(+) With Europe Participation in EUREKA, 
Galileo, EEN. 
32 Global Research 
Infrastructures 
The design of VATAT 
2010, includes a six-year 
programme fund for 
universities, includes the 
development of the RIs 
needed by Israel. 
 (+) Although this measure is not applicable 
to Israel. Israel is aware of the development of 
RI and are included in the VATAT 
programme. 
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33 National Reform 
Programmes 
 Not applicable to Israel.   
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ANNEX 3.  NATIONAL PROGRESS 
TOWARDS REALISATION OF ERA 
 
ERA Priority ERA Action Recent changes Assessment of progress 
in delivering ERA 
1. More effective 
national research 
systems 
Action 1: Introduce or 
enhance competitive 
funding through calls for 
proposals and institutional 
assessments 
-Amendment of basic 
industrial R&D (1984) law 
 
-TMURA. Encouraging 
large firms to set up 
development centres in 
peripheral areas 
 
(+) 37% of the total 
funding for innovation is 
done through competitive 
funding.  
 
Action 2: Ensure that all 
public bodies responsible 
for allocating research 
funds apply the core 
principles of international 
peer review 
 -n.a.  (+) The funding is done 
following international 
standards.  
 
2. Optimal 
transnational co-
operation and 
competition  
Action 1: Step up efforts 
to implement joint 
research agendas 
addressing grand 
challenges, sharing 
information about 
activities in agreed priority 
areas, ensuring that 
adequate national funding 
is committed and 
strategically aligned at 
European level in these 
areas  
-Israel is conected with 
Europe as whole via 
EUREKA, FP7 and COST. 
 
 (+) Very good international 
network.  
Action 2: Ensure mutual 
recognition of evaluations 
that conform to 
international peer-review 
standards as a basis for 
national funding decisions 
 -n.a.  (+) Evaluation follow 
international peer-review 
standards. 
Action 3: Remove legal 
and other barriers to the 
cross-border 
interoperability of 
national programmes to 
permit joint financing of 
actions including 
cooperation with non-EU 
countries where relevant  
-Israel has bilateral 
cooperation agreements 
with US, Japan, Canada, 
India, Russia, South Korea 
and Singapore. 
 (+) Positive evolution. 
Action 4:  Confirm 
financial commitments 
for the construction and 
operation of ESFRI, 
global, national and 
regional RIs of pan-
European interest, 
particularly when 
 -Israel participates in 
ESFRI as a non-member 
state. 
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developing national 
roadmaps and the next SF 
programmes 
Action 5: Remove legal 
and other barriers to 
cross-border access to RIs 
-As a non member state 
Israel is not required. 
However aware of the 
needs for new Research 
Infrastructure and takes 
cares under VATAT and I-
CORE programmes. 
 (+) The country is aware of 
the needs for Research 
Infrastructure. 
ERA priority 3: An 
open labour market 
for researchers 
Action 1: Remove legal 
and other barriers to the 
application of open, 
transparent and merit 
based recruitment of 
researchers 
 I-CORE. Setting of 20 
Research Centers in Israel 
to bring back Israeli and 
International researchers. 
 (+) Well implemented in 
Israel.  
Action 2: Remove legal 
and other barriers which 
hamper cross-border 
access to and portability 
of national grants 
 n.a.  (-) Most of the funding are 
not portable outside Israel. 
Action 3: Support 
implementation of the 
Declaration of 
Commitment to provide 
coordinated personalised 
information and services 
to researchers through the 
pan-European 
EURAXESS3 network 
 n.a.   
Action 4: Support the 
setting up and running of 
structured innovative 
doctoral training 
programmes applying the 
Principles for Innovative 
Doctoral Training. 
n.a.   
Action 5: Create an 
enabling framework for 
the implementation of the 
HR Strategy for 
Researchers incorporating 
the Charter & Code 
-The Technion is 
acknowledged by the the 
EC, as working with the 
best practice of the 
European Charter of 
Researcher and the Code of 
Conduct for the 
Recruitment of Researchers. 
 
  
ERA priority 4: 
Gender equality and 
gender 
mainstreaming in 
research 
Action 1: Create a legal 
and policy environment 
and provide incentives  
 n.a.  (+) The situation of 
women participation in 
Israel is similar to any other 
advance economy in the 
world. 
(-) No change is taking 
place. 
Action 2: Engage in 
partnerships with funding 
agencies, research 
organisations and 
universities to foster 
cultural and institutional 
change on gender  
 n.a.  (-) No change is taking 
place. 
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Action  3: Ensure that at 
least 40% of the under-
represented sex 
participate in committees 
involved in  
recruitment/career 
progression and in 
establishing and 
evaluating 
 n.a.  (-) No change is taking 
place. 
ERA priority 5: 
Optimal circulation, 
access to and 
transfer of scientific 
knowledge 
including via digital 
ERA 
Action 1: Define and 
coordinate their policies 
on access to and 
preservation of scientific 
information  
-Magnet. 
-Nofar 
-Kadmin. 
 (+) Fluent transfer of 
knowledge.  
Action 2: Ensure that 
public research 
contributes to Open 
Innovation and foster 
knowledge transfer 
between public and 
private sectors through 
national knowledge 
transfer strategies 
 -n.a.  (-) No changes 
Action 3: Harmonise 
access and usage policies 
for research and 
education-related public 
e-infrastructures and for 
associated digital research 
services enabling 
consortia of different 
types of public and 
private partners 
 n.a.  (-) No changes 
Action 4: Adopt and 
implement national 
strategies for electronic 
identity for researchers 
giving them transnational 
access to digital research 
services 
 n.a.  (-) No changes 
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